Emergent BioSolutions Inc. provided revenue guidance for the second quarter of 2024. For the quarter, the company reported total revenue of $160 million to $210 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.27 USD | -7.71% | +20.59% | +119.58% |
May. 02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 02 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+119.58% | 276M | |
+32.36% | 694B | |
+30.12% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.40% | 239B | |
+10.14% | 209B | |
-3.19% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Emergent BioSolutions Inc. Provides Revenue Guidance for the Second Quarter of 2024